122 results
S-8
EX-99.2
NTBL
Notable Labs Ltd
19 Apr 24
Registration of securities for employees
4:56pm
to the Plan (“Awards”).
The Plan is designed to comply with Section 102 of the Israeli Income Tax Ordinance (New Version), 1961, as amended from time … , does not warrant that the Plan will be recognized by the income tax authorities or that future changes will not be made to the provisions of the law
8-K
EX-99.1
NTBL
Notable Labs Ltd
12 Apr 24
Notable Labs Reports 2023 Financial Results and Provides a Business Update
8:44am
or local legislative requirements, such as changes in or additions to tax laws or rates, pharmaceutical regulations, and other regulations. Actual results
8-K
EX-99.1
2b935esuj2y6ebi
9 Apr 24
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
5:20pm
8-K
EX-99.1
bh3sokzsnnnapc42t0q
8 Apr 24
Other Events
12:15pm
8-K
EX-99.1
zry ps3b86une2ihue6g
22 Feb 24
Other Events
8:15am
DEF 14A
nnli54tm11641
16 Feb 24
Definitive proxy
9:00am
PRE 14A
oz5xq9u 1f005xy
5 Feb 24
Preliminary proxy
5:00pm
8-K
EX-99.1
t41jy52ecla2tn
18 Dec 23
Other Events
8:15am
8-K/A
EX-99.3
hn0lto8 gc0
29 Nov 23
Financial Statements and Exhibits
5:15pm
8-K/A
EX-99.4
0o89kg
29 Nov 23
Financial Statements and Exhibits
5:00pm
8-K/A
EX-99.2
4jwkzcg0idwx9
29 Nov 23
Financial Statements and Exhibits
5:00pm
8-K/A
EX-99.3
1dt9utux
29 Nov 23
Financial Statements and Exhibits
5:00pm
8-K
EX-99.1
p9xzf9n8 8nn
14 Nov 23
Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023
12:00am
S-3
ltcn ll3elq8
17 Oct 23
Shelf registration
5:01pm
8-K
kshlm2ug
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
8-K
EX-10.4
kl3pcuec 51qcvnkdf
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm